Lantheus Holdings (ISIN US5165441032) had a USD 6.5 billion market capitalization on October 7, 2026. The company is moving ...

Wellspect HealthCare has announced that the Surity portfolio, including the Surity Urinary Management System and Surity Female and Male External Catheters, may be covered by traditional ...

Medical offices bill insurance providers for clients' services. Learn what's involved, including HIPAA regulations, what to ...

Medical billing and coding systems ensure that health providers get paid for their services. Learn the steps in medical ...

Traditional Medicare reimbursement supports broader access to non-invasive management options for eligible beneficiaries living with permanent ...

HCPCS code E0150 — defined as “Combination wheeled walker with seat and transport chair, folding, adjustable or fixed height” ...

Wandercraft acquires Ekso Bionics to form the world's leading medical exoskeleton company, uniting Atalante X, EksoNR, Eve, ...

ISELIN - Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on the development and commercialization of LYTENAVA (bevacizumab-vikg, bevacizumab gamma) for the treatment of ...

The Choices for Increased Mobility Act, H.R. 1703, passed the U.S. Senate by unanimous consent on Sept. 30, clearing its final legislative hurdle.

Outlook Therapeutics, Inc. announced that it has submitted an application to the Centers for Medicare & Medicaid Services (CMS) requesting a permanent, product-specific Healthcare Common Procedure ...

Application represents an important step in supporting reimbursement Company remains on track for U.S. commercial launch of LYTENAVA before year-end 2026 ISELIN, N.J., Oct. 01, 2026 (GLOBE NEWSWIRE) ...

Application represents an important step in supporting reimbursement Company remains on track for U.S. commercial launch of LYTENAVA before year-end 2026 ISELIN, N.J., Oct. 01, 2026 (GLOBE NEWSWIRE) - ...